Addus HomeCare Co. (NASDAQ:ADUS) Shares Bought by Martingale Asset Management L P

Martingale Asset Management L P grew its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 1.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,381 shares of the company’s stock after purchasing an additional 482 shares during the period. Martingale Asset Management L P owned 0.15% of Addus HomeCare worth $3,642,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. UMB Bank n.a. boosted its position in shares of Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares during the last quarter. Quest Partners LLC acquired a new stake in shares of Addus HomeCare in the second quarter worth approximately $31,000. Innealta Capital LLC acquired a new stake in shares of Addus HomeCare in the second quarter worth approximately $44,000. Farther Finance Advisors LLC boosted its position in shares of Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after acquiring an additional 366 shares during the last quarter. Finally, Sandia Investment Management LP acquired a new stake in shares of Addus HomeCare in the second quarter worth approximately $58,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on ADUS shares. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. KeyCorp initiated coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. TD Cowen raised their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Royal Bank of Canada restated an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. Finally, Oppenheimer raised their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Stock Up 1.3 %

ADUS opened at $122.84 on Friday. The firm has a market capitalization of $2.23 billion, a P/E ratio of 28.11, a P/E/G ratio of 2.12 and a beta of 1.04. The firm’s 50 day moving average is $127.45 and its 200-day moving average is $123.48. Addus HomeCare Co. has a 52-week low of $85.43 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.03 earnings per share. Equities analysts expect that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at approximately $429,165. This represents a 12.93 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,500 shares of company stock worth $1,668,265. Insiders own 4.60% of the company’s stock.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.